Jeff Swiatek got an opportunity to interview Ronald D. Henriksen, an innovator and former Lilly executive who was there when biotechnology revolution started in 1976 and when world’s leading biotech engineers came together for comparing their notes at Eli Lilly. In 1993 Henriksen left Lilly and started hi career in venture financing and tech startups. Now he is the CEO of two biotech startups called Semafore Pharmaceuticals and EndGenitor Technologies. This an intensive interview which has focused around the biotechnology field and his work involved. To read the whole interview click here.